Search Results - "Shao, Z.M."

Weekly paclitaxel plus carboplatin is an effective nonanthracycline-containing regimen as neoadjuvant chemotherapy for breast cancer by Chen, X.S., Nie, X.Q., Chen, C.M., Wu, J.Y., Wu, J., Lu, J.S., Shao, Z.M., Shen, Z.Z., Shen, K.W.

“…Background: To evaluate the activity and safety of nonanthracycline-containing weekly PCb [paclitaxel (Taxol) plus carboplatin] regimen in neoadjuvant…”
Get full text

The predictive and prognostic significance of pre- and post-treatment topoisomerase IIα in anthracycline-based neoadjuvant chemotherapy for local advanced breast cancer by Chen, S, Huang, L, Liu, Y, Chen, C.M, Wu, J, Shao, Z.M

“…Abstract Objective To investigate the predictive and prognostic value of topoisomerase IIα (Topo IIα, Topo II) expression in the primary tumors and residual…”
Get full text

440 Prognostic Value of a Positive-to-negative Change in Hormonal Receptor Status Following Neoadjuvant Chemotherapy in Patients with Luminal-type Breast Cancer by Chen, S, Chen, C.M, Yu, K.D, Zhou, R.J, Shao, Z.M

Get full text

439 Significantly Higher Pathologic Complete Response Rate with Weekly Compared with Three-weekly Paclitaxel and Carboplatin Plus Trastuzumab Neoadjuvant Therapy – Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2-positive Breast Cancer by Shao, Z.M, Chen, C.M, Zhou, Y, Chen, S, Hou, Y.F, Liu, G.Y, Di, G.H, Lu, J.S, Wu, J, Shen, Z.Z

Get full text

131 A straightforward but not piecewise relationship between age and lymph node status in Chinese breast cancer patients by Yu, K.D, Shao, Z.M

Get full text

419 Optimizing adjuvant endocrine therapy for postmenopausal breast cancer: the modified CYP2D6 genotype-based modeling analyses by Di, G.H, Shao, Z.M, Yu, K.D

Get full text

IHC-based and mRNA-based subtyping for Triple-negative breast cancer by Zhao, S., Tong, C., Qian, F.J., Yuan, X.Y., Zhang, Q., Li, X.M., Yang, W.T., Shao, Z.M.

Get full text

104 Molecular biomarkers to predict neoadjuvant chemotherapy response in breast cancer patients treated with weekly paclitaxel plus carboplatin by Chen, X.S, Wu, J.Y, Shen, K.W, Lu, H.F, Lu, J.S, Wu, J, Shao, Z.M, Shen, Z.Z

Get full text

P162 Time distribution of mortality risk for breast cancer and its clinical application by Yin, W.J, Lu, J.S, Liu, G.Y, Di, G.H, Wu, J, Shen, K.W, Shen, Z.Z, Shao, Z.M

Get full text

536 Patterns of care and safety profiles of adjuvant docetaxel-based chemotherapy regimens in a large breast cancer registry study in Asia Pacific by Yau, T.K, Sayeed, A, Shen, Z.Z, Kim, S.B, Ali Shah, M, Villalon, A.H, Hou, M.F, Thuan, T.V, Shao, Z.M, Kim, J.H

Get full text

A study on the relationship between breast cancer molecular classification and prognosis by Chen, X.S, Shen, K.W, Yang, W.T, Lu, H.F, Wu, J, Lu, J.S, Shao, Z.M, Shen, Z.Z

Get full text

Biomarker assessment of the CBCSG006 trial: a randomized phase III trial of cisplatin plus gemcitabine compared with paclitaxel plus gemcitabine as first-line therapy for patients with metastatic triple-negative breast cancer by Zhang, J., Lin, Y., Sun, X.J., Wang, B.Y., Wang, Z.H., Luo, J.F., Wang, L.P., Zhang, S., Cao, J., Tao, Z.H., Wu, J., Shao, Z.M., Yang, W.T., Hu, X.C.

“…CBCSG006 trial reported the superior efficacy of cisplatin plus gemcitabine (GP) regimen than paclitaxel plus gemcitabine (GT) regimen as first-line treatment…”
Get full text

Circulating tumor cells predict progression-free and overall survival in Chinese patients with metastatic breast cancer, HER2-positive or triple-negative (CBCSG004): a multicenter, double-blind, prospective trial by Jiang, Z.F., Cristofanilli, M., Shao, Z.M., Tong, Z.S., Song, E.W., Wang, X.J., Liao, N., Hu, X.C., Liu, Y., Wang, Y., Zeng, L., Zhang, M.

“…The aim of this multicenter, double-blind, prospective study was to evaluate the potential utility of circulating tumor cell (CTC) measurements in predicting…”
Get full text

67P Analysis of Local-Regional Recurrence in Young Women (≤ 35Y) Receiving Mastectomy for Operable Breast Cancer by Tang, L.C., Zhu, C.Y., Di, G.H., Ma, J.L., Yang, Z.Z., Yu, X.L., Shao, Z.M., Chen, J.Y.

Get full text

Potential impact of cardiac dose–volume on acute cardiac toxicity following concurrent trastuzumab and radiotherapy by Cao, L., Hu, W.G., Kirova, Y.M., Yang, Z.Z., Cai, G., Yu, X.L., Ma, J.L., Guo, X.M., Shao, Z.M., Chen, J.Y.

“…To analyse the risk factors associated with acute cardiotoxicity in HER2-positive breast cancer patients receiving concurrent trastuzumab and radiotherapy…”
Get full text

Effects of rehabilitation management on gastric emptying function in older adults with diabetes by Shao, Z M, Yao, J F, Chen, J, Yu, Z W, Yu, X F, Zheng, J J, Tang, X

“…The relationship between gastric emptying dysfunction and blood glucose concentration in elderly with type 2 diabetes mellitus was investigated, and the effect…”
Get full text

Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-alpha acquire sensitivity to growth inhibition by retinoids by Sheikh, M S, Shao, Z M, Li, X S, Dawson, M, Jetten, A M, Wu, S, Conley, B A, Garcia, M, Rochefort, H, Fontana, J A

“…Retinoids mediate their actions via RARs (retinoic acid receptors) and RXRs (retinoid X receptors). Each class of these nuclear retinoid receptors is further…”
Get full text

Retinoic acid and estrogen modulation of insulin-like growth factor binding protein-4 gene expression and the estrogen receptor status of human breast carcinoma cells by Sheikh, M S, Shao, Z M, Hussain, A, Chen, J C, Roberts, Jr, C T, LeRoith, D, Fontana, J A

“…Retinoic acid (RA) and estrogen modulation of insulin like-growth factor binding protein-4 (IGFBP-4) gene expression was investigated in a number of human…”
Get more information